Terms: = Uterine cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Clinical Outcome
2 results:
1. CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer.
Tanaka T; Terai Y; Kogata Y; Ashihara K; Maeda K; Fujiwara S; Yoo S; Tanaka Y; Tsunetoh S; Sasaki H; Kanemura M; Tanabe A; Ohmichi M
Oncol Rep; 2015 Nov; 34(5):2282-8. PubMed ID: 26351781
[TBL] [Abstract] [Full Text] [Related]
2. Loss of RKIP expression during the carcinogenic evolution of endometrial cancer.
Martinho O; Faloppa CC; Neto CS; Longatto-Filho A; Baiocchi G; da Cunha IW; Soares FA; Fregnani JH; Reis RM
J Clin Pathol; 2012 Feb; 65(2):122-8. PubMed ID: 22031589
[TBL] [Abstract] [Full Text] [Related]